Digital Life Sciences took part in PharmaCongress and PharmaTechnica Expo 2026, engaging in valuable exchange on the latest developments in regulated environments.
Particular focus was placed on key topics shaping the future, including the evolution of regulatory requirements, the use of AI-driven technologies, and the increasing digitalisation of quality and production processes. The accompanying conference programme provided valuable insights and underlined the pace of change in the industry.
Discussions at the Digital Life Sciences exhibition stand highlighted a clear trend: companies are increasingly focusing on solutions to make document-driven processes more efficient while enhancing transparency and ensuring audit compliance. A key focus was on digital workflows to streamline the management of SOPs, work instructions, and review processes.
In this context, Digital Life Sciences presented approaches to an integrated digital document and quality management system designed to support compliance with regulatory requirements while improving operational processes.
We would like to thank all visitors for the engaging discussions and valuable insights into both current challenges and future industry needs.
